ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DDDD 4d Pharma Plc

16.36
0.00 (0.00%)
04 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 16.36 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

4d Pharma Share Discussion Threads

Showing 38576 to 38596 of 39350 messages
Chat Pages: Latest  1550  1549  1548  1547  1546  1545  1544  1543  1542  1541  1540  1539  Older
DateSubjectAuthorDiscuss
04/8/2022
17:13
"A decent chunk for shareholders after creditors is still viable"...Come on buddy that's like wishing on the nigh impossible but good to see that ones still continues to have buckets of optimism!
one_frankel
04/8/2022
17:07
Totally agree .... unbelievable to be honest....
amaretto1
04/8/2022
17:06
amaretto,

....all for a banking covenant breach which the Directors should have been aware of and not let happen.

sportbilly1976
04/8/2022
16:54
DDDD mkt cap 28 million uk !!
amaretto1
04/8/2022
16:52
I've take that bill from the other bank account..... :-) seriously Seres mkt cap today is nearly 600 million. ..... yes 600 million !! What's DDDD closing price ??
amaretto1
04/8/2022
16:49
That's 7m USD. However at 650 GBP per hour that'll soon be gone.
katsy
04/8/2022
16:47
A decent chunk for shareholders (after creditors) is still viable

I like that offers have been invited (50 pharmas ) and a deadline set. It fosters a competitive spirit.

Its like a tender process.

We all got in here believing going forward this was worth billions. Mgt too regularly backed it with their wallets.

Lets see how right - or wrong - we were.

a £100m+ offer wouldn't suprise.

We all wanted a big buyout.

How ironic if it happened via this route.

backbone and clingfilm
04/8/2022
16:42
...Because willing parties are not stupid to pay over the odds albeit in a very concerning market environment and they will fully capitalise on 4Ds desperate situation...Its simply 'Business' to them where nothing else counts unfortunately!
one_frankel
04/8/2022
16:40
Unless there's a bidding war, any one bidding will simply place a take it or leave it offer. 4d admins are not in a bargaining position.
katsy
04/8/2022
16:38
DDDD have still 7 million in the bank They owe 13 million ...Just saying
amaretto1
04/8/2022
16:36
Won't us share holders get .... what OF have not got the lien on ? It's all very complicated The fact they have asked over 50 bio companies if they want it .....Might ... i mean might ... may spur Merk to do something..Anyway .... still Zero in my head
amaretto1
04/8/2022
16:36
To be fair to them the Administrators seem to have contacted more potential Pharma/Biotech buyers than 4D's Management ever did. I fail to see how shopping this Company that widely can not lead to a decent bid or refinancing proposal to emerge.

Sale of business

As alluded to above, we commenced a sale of business process shortly after appointment. We have contacted nearly fifty large pharmaceutical businesses and smaller biotechnology companies (including other prominent players in the microbiome space).

Due to the commercial sensitivity of this sales process, we can only provide limited narrative as to the exact progress to date. Offer deadlines have been set with all interested parties and the details of indicative offers received cannot be disclosed subject to confidentiality agreement provisions.

Alongside the above sale of business activity, we continue to explore the possibility of a refinance of the Group and an exit from administration. Similarly to above, progress here is confidential and updates will be made available to creditors at the appropriate time.

Should no viable offers emerge during the sale of business process, our strategy will likely be to minimise costs to preserve the Company's main asset, floating charge cash, and realise the Company's other assets.

thiopia
04/8/2022
16:32
Its unfortunate but I think so Cornetto and if there was to be any traction for existing investors, it will be for next to nothing, monies will be chewed up with the prolonged process, its standard bloody practice for them.
one_frankel
04/8/2022
16:28
So what's the verdict ? Zero
amaretto1
04/8/2022
16:27
Dividend to unsecured creditors normally refers to company suppliers, customers, HMRC and contractors but they rank after secured and preferential creditors in an insolvency situation.
one_frankel
04/8/2022
16:25
Seems reasonable no? Administrators are considered the biggest sharks of the lot.
katsy
04/8/2022
16:24
#30012

Shareholders are not classed as unsecured creditors. In effect shareholders are not owed anything by the company, they are beneficial owners of whatever value is left when assets are disposed of after all other classes of creditors are paid off. This is more often than not zilch, given the reason that businesses are usually put into administration is their inability to pay debts as they fall due, and continue to trade, after unsuccessfully exploring other funding options.

monte1
04/8/2022
16:22
A very interesting and detailed RNS but for all that little progress really. Oxford have achieved their objective though in securing their money. Played it well to be fair to them.
nigelpm
04/8/2022
16:19
RNS states Refinancing is still being explored too.

Promising

backbone and clingfilm
04/8/2022
16:17
I've mentally written the lot off
amaretto1
04/8/2022
16:16
Dividend for unsecured creditors .. what's that ? Share holders
amaretto1
Chat Pages: Latest  1550  1549  1548  1547  1546  1545  1544  1543  1542  1541  1540  1539  Older